National Cancer Survivor Day

This coming Sunday, June 7, is National Cancer Survivors Day. This will mark the 27th anniversary of this event To learn more about National Cancer Survivor Day you can Visit the following site National Cancer Survivors Day Foundation I am proud to be a part of the brotherhood and sisterhood of cancer survivors. Joel T [...]

Omega-3: Increase Your Intake of Omega-3 with Krill Oil Instead of Fish Oil

Our diet is always a point of a major conversation around cancer prevention and control. This is no different for prostate cancer prevention and control. Many of us have made a serious attempt to add fish oil (omega-3 oils) to our diet to fight inflammation, a major no-no in cancer fighting. That’s got to be [...]

Increased Survival Demonstrated in a Phase II Trial of OGX-011

Results from a randomized phase II study presented Saturday at the American Society of Clinical Oncology (ASCO) annual meeting indicates there might be a new drug on the horizon for men with advanced prostate cancer. OncoGenex Pharmaceuticals drug known as OGX-011 extended the survival of patients with advanced prostate cancer by almost seven months in [...]

Slow Down Prostate Cancer Tumors by Controlling Your Intake of Carbohydrates

Prostate cancer and diet has been strongly link for a while. We are told to eat a Mediterranean style diet or to become a vegetarian. Being over weight has been strongly linked to having a prostate cancer recurrence. This week's online edition of the journal Cancer Prevention Research states that cutting back on carbohydrates appears [...]

Toxicity and Efficacy of Intermittent Docetaxel Chemotherapy for Hormone Refractory Prostate Cancer

Once we become hormone refractory (HRPC) there remains only one approved drug to treat our prostate cancer, docetaxel. As with hormone therapy (ADT) docetaxel also stops working after a period. There have been different strategies used to try to deal with this untenable situation, including the use of docetaxel on an intermittent schedule. A recent [...]

Go to Top